Lymphocyte Trafficking in Inflammatory Bowel Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Feagan B, Rutgeerts P, Sands B, Hanauer S, Colombel J, Sandborn W
. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013; 369(8):699-710.
DOI: 10.1056/NEJMoa1215734.
View
2.
Sandborn W, Feagan B, Rutgeerts P, Hanauer S, Colombel J, Sands B
. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med. 2013; 369(8):711-21.
DOI: 10.1056/NEJMoa1215739.
View
3.
Sandborn W, Feagan B, DHaens G, Wolf D, Jovanovic I, Hanauer S
. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2021; 385(14):1280-1291.
DOI: 10.1056/NEJMoa2033617.
View
4.
Sandborn W, Vermeire S, Peyrin-Biroulet L, Dubinsky M, Panes J, Yarur A
. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies. Lancet. 2023; 401(10383):1159-1171.
DOI: 10.1016/S0140-6736(23)00061-2.
View